Drug Delivery Devices Market Report

Drug Delivery Devices Market - Global Professional Analysis and Forecast to 2026

  • POSTDATE：Jan 26, 2020
  • PAGES：192
  • REPORT CODE：GMM449104
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The worldwide Drug Delivery Devices market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 15.1% during the forecast period.

    This report presents the market size and development trends by detailing the Drug Delivery Devices market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Drug Delivery Devices market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Drug Delivery Devices industry and will help you to build a panoramic view of the industrial development.

    Drug Delivery Devices Market, By Type:

    • Injection type

    • Mucosal type

    • Implanted type

    • Others type

    Drug Delivery Devices Market, By Application:

    • Pharmaceutical companies

    • Hospitals

    • Clinics

    • Other

    Some of the leading players are as follows:

    • Skyepharma

    • COVIDIEN Medtronic

    • Roche

    • Chiesi

    • Catalent

    • Novartis AG

    • B.Braun

    • Johnson & Johnson

    • Zhengkang

    • 3M

    • Pfizer

    • Phillips-Medisize

    • BBraun

    • Boehringer Ingelheim

    • Bayer AG

    • Baxter International

    • Shandong Weigao

    • Valeant Pharmaceuticals

    • Cipla

    • Schott forma vitrum

    • Allergan

    • BD

    • Alkermes

    • Nipro Corporation

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Methodology and Scope

    • 1.1 Market Segmentation & Scope

      • 1.1.1 Technology Type

      • 1.1.2 Product

      • 1.1.3 Application

      • 1.1.4 Regional scope

      • 1.1.5 Estimates and forecast timeline

    • 1.2 Research Methodology

    • 1.3 Information Procurement

      • 1.3.1 Purchased database

      • 1.3.2 Internal database

      • 1.3.3 Secondary sources

      • 1.3.4 Primary research

      • 1.3.5 Details of primary research

    • 1.4 Information or Data Analysis

      • 1.4.1 Data analysis models

    • 1.5 Market Formulation & Validation

    • 1.6 Model Details

      • 1.6.1 Commodity flow analysis

      • 1.6.2 Volume price analysis

    • 1.7 List of Secondary Sources

    • 1.8 List of Abbreviations

    2 Executive Summary

    • 2.1 Market Outlook

    • 2.2 Segment Outlook

    3 Market Variables, Trends, & Scope

    • 3.1 Market Lineage Outlook

    • 3.1.1 Parent market outlook

      • 3.1.2 Ancillary market outlook

    • 3.2 Market Segmentation

      • 3.2.1 Analysis

    • 3.3 Market Dynamics

      • 3.3.1 Market driver analysis

      • 3.3.2 Market restraint analysis

      • 3.3.3 Industry opportunities

    • 3.4 Penetration & Growth Prospect Mapping

      • 3.4.1 Penetration & growth prospect mapping analysis

    • 3.5 Business Environment Analysis Tools

      • 3.5.1 Porter's five forces analysis

      • 3.5.2 PESTLE analysis

      • 3.5.3 Major deals & strategic alliances analysis

    4 Drug Delivery Devices Market: Technology Type Analysis

    • 4.1 Drug Delivery Devices Technology Type Market Share Analysis, 2018 & 2026

    • 4.2 Drug Delivery Devices Technology Type Market: Segment Dashboard

    • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

      • 4.3.1 Injection type

      • 4.3.2 Mucosal type

      • 4.3.3 Implanted type

      • 4.3.4 Others type

    5 Drug Delivery Devices Market: Product Analysis

    • 5.1 Drug Delivery Devices Product Market Share Analysis, 2018 & 2026

    • 5.2 Drug Delivery Devices Product Market: Segment Dashboard

    • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

    6 Drug Delivery Devices Market: Application Analysis

    • 6.1 Drug Delivery Devices Application Market Share Analysis, 2018 & 2026

    • 6.2 Drug Delivery Devices Application Market: Segment Dashboard

    • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

      • 6.3.1 Pharmaceutical companies

      • 6.3.2 Hospitals

      • 6.3.3 Clinics

      • 6.3.4 Other

    7 Drug Delivery Devices Market: Regional Analysis

    • 7.1 Drug Delivery Devices Regional Market Share Analysis, 2018 & 2026

    • 7.2 Drug Delivery Devices Regional Market: Segment Dashboard

    • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

    • 7.4 List of Players at Regional Level

      • 7.4.1 North America

      • 7.4.2 Europe

      • 7.4.3 Asia Pacific

    • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

      • 7.5.1 North America

      • 7.5.2 Europe

      • 7.5.3 Asia Pacific

      • 7.5.4 Latin America

      • 7.5.5 MEA

    • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

      • 7.6.1 North America

      • 7.6.2 Europe

      • 7.6.3 Asia Pacific

      • 7.6.4 Latin America

      • 7.6.5 Middle East & Africa

    8 Competitive Analysis

    • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

    • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

    • 8.3 Vendor Landscape

      • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

    9 Company Profiles

    • 9.1 Skyepharma

      • 9.1.1 Skyepharma Company overview

      • 9.1.2 Financial performance

      • 9.1.3 Product benchmarking

      • 9.1.4 Strategic initiatives

      • 9.1.5 SWOT analysis

    • 9.2 COVIDIEN Medtronic

      • 9.2.1 COVIDIEN Medtronic Company overview

      • 9.2.2 Financial performance

      • 9.2.3 Product benchmarking

      • 9.2.4 Strategic initiatives

      • 9.2.5 SWOT analysis

    • 9.3 Roche

      • 9.3.1 Roche Company overview

      • 9.3.2 Financial performance

      • 9.3.3 Product benchmarking

      • 9.3.4 Strategic initiatives

      • 9.3.5 SWOT analysis

    • 9.4 Chiesi

      • 9.4.1 Chiesi Company overview

      • 9.4.2 Financial performance

      • 9.4.3 Product benchmarking

      • 9.4.4 Strategic initiatives

      • 9.4.5 SWOT analysis

    • 9.5 Catalent

      • 9.5.1 Catalent Company overview

      • 9.5.2 Financial performance

      • 9.5.3 Product benchmarking

      • 9.5.4 Strategic initiatives

      • 9.5.5 SWOT analysis

    • 9.6 Novartis AG

      • 9.6.1 Novartis AG Company overview

      • 9.6.2 Financial performance

      • 9.6.3 Product benchmarking

      • 9.6.4 Strategic initiatives

      • 9.6.5 SWOT analysis

    • 9.7 B.Braun

      • 9.7.1 B.Braun Company overview

      • 9.7.2 Financial performance

      • 9.7.3 Product benchmarking

      • 9.7.4 Strategic initiatives

      • 9.7.5 SWOT analysis

    • 9.8 Johnson & Johnson

      • 9.8.1 Johnson & Johnson Company overview

      • 9.8.2 Financial performance

      • 9.8.3 Product benchmarking

      • 9.8.4 Strategic initiatives

      • 9.8.5 SWOT analysis

    • 9.9 Zhengkang

      • 9.9.1 Zhengkang Company overview

      • 9.9.2 Financial performance

      • 9.9.3 Product benchmarking

      • 9.9.4 Strategic initiatives

      • 9.9.5 SWOT analysis

    • 9.10 3M

      • 9.10.1 3M Company overview

      • 9.10.2 Financial performance

      • 9.10.3 Product benchmarking

      • 9.10.4 Strategic initiatives

      • 9.10.5 SWOT analysis

    • 9.11 Pfizer

      • 9.11.1 Pfizer Company overview

      • 9.11.2 Financial performance

      • 9.11.3 Product benchmarking

      • 9.11.4 Strategic initiatives

      • 9.11.5 SWOT analysis

    • 9.12 Phillips-Medisize

      • 9.12.1 Phillips-Medisize Company overview

      • 9.12.2 Financial performance

      • 9.12.3 Product benchmarking

      • 9.12.4 Strategic initiatives

      • 9.12.5 SWOT analysis

    • 9.13 BBraun

      • 9.13.1 BBraun Company overview

      • 9.13.2 Financial performance

      • 9.13.3 Product benchmarking

      • 9.13.4 Strategic initiatives

      • 9.13.5 SWOT analysis

    • 9.14 Boehringer Ingelheim

      • 9.14.1 Boehringer Ingelheim Company overview

      • 9.14.2 Financial performance

      • 9.14.3 Product benchmarking

      • 9.14.4 Strategic initiatives

      • 9.14.5 SWOT analysis

    • 9.15 Bayer AG

      • 9.15.1 Bayer AG Company overview

      • 9.15.2 Financial performance

      • 9.15.3 Product benchmarking

      • 9.15.4 Strategic initiatives

      • 9.15.5 SWOT analysis

    • 9.16 Baxter International

      • 9.16.1 Baxter International Company overview

      • 9.16.2 Financial performance

      • 9.16.3 Product benchmarking

      • 9.16.4 Strategic initiatives

      • 9.16.5 SWOT analysis

    • 9.17 Shandong Weigao

      • 9.17.1 Shandong Weigao Company overview

      • 9.17.2 Financial performance

      • 9.17.3 Product benchmarking

      • 9.17.4 Strategic initiatives

      • 9.17.5 SWOT analysis

    • 9.18 Valeant Pharmaceuticals

      • 9.18.1 Valeant Pharmaceuticals Company overview

      • 9.18.2 Financial performance

      • 9.18.3 Product benchmarking

      • 9.18.4 Strategic initiatives

      • 9.18.5 SWOT analysis

    • 9.19 Cipla

      • 9.19.1 Cipla Company overview

      • 9.19.2 Financial performance

      • 9.19.3 Product benchmarking

      • 9.19.4 Strategic initiatives

      • 9.19.5 SWOT analysis

    • 9.20 Schott forma vitrum

      • 9.20.1 Schott forma vitrum Company overview

      • 9.20.2 Financial performance

      • 9.20.3 Product benchmarking

      • 9.20.4 Strategic initiatives

      • 9.20.5 SWOT analysis

    • 9.21 Allergan

      • 9.21.1 Allergan Company overview

      • 9.21.2 Financial performance

      • 9.21.3 Product benchmarking

      • 9.21.4 Strategic initiatives

      • 9.21.5 SWOT analysis

    • 9.22 BD

      • 9.22.1 BD Company overview

      • 9.22.2 Financial performance

      • 9.22.3 Product benchmarking

      • 9.22.4 Strategic initiatives

      • 9.22.5 SWOT analysis

    • 9.23 Alkermes

      • 9.23.1 Alkermes Company overview

      • 9.23.2 Financial performance

      • 9.23.3 Product benchmarking

      • 9.23.4 Strategic initiatives

      • 9.23.5 SWOT analysis

    • 9.24 Nipro Corporation

      • 9.24.1 Nipro Corporation Company overview

      • 9.24.2 Financial performance

      • 9.24.3 Product benchmarking

      • 9.24.4 Strategic initiatives

      • 9.24.5 SWOT analysis

     

    The List of Tables and Figures (Totals 86 Figures and 133 Tables)

    • Figure Injection type Drug Delivery Devices market, 2015 - 2026 (USD Million)

    • Figure Mucosal type Drug Delivery Devices market, 2015 - 2026 (USD Million)

    • Figure Implanted type Drug Delivery Devices market, 2015 - 2026 (USD Million)

    • Figure Others type Drug Delivery Devices market, 2015 - 2026 (USD Million)

    • Figure Pharmaceutical companies market, 2015 - 2026 (USD Million)

    • Figure Hospitals market, 2015 - 2026 (USD Million)

    • Figure Clinics market, 2015 - 2026 (USD Million)

    • Figure Other market, 2015 - 2026 (USD Million)

    • Table List of players in North America

    • Table List of players in Europe

    • Table List of players in Asia Pacific

    • Table SWOT analysis

    • Table North America Drug Delivery Devices market, by country, 2015 - 2026 (USD Million)

    • Table North America Drug Delivery Devices market, by type, 2015 - 2026 (USD Million)

    • Table North America Drug Delivery Devices market, by product, 2015 - 2026 (USD Million)

    • Table North America Drug Delivery Devices market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.S. Drug Delivery Devices market, by type, 2015 - 2026 (USD Million)

    • Table U.S. Drug Delivery Devices market, by product, 2015 - 2026 (USD Million)

    • Table U.S. Drug Delivery Devices market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Canada Drug Delivery Devices market, by type, 2015 - 2026 (USD Million)

    • Table Canada Drug Delivery Devices market, by product, 2015 - 2026 (USD Million)

    • Table Canada Drug Delivery Devices market, by application, 2015 - 2026 (USD Million)

    • Table Europe Drug Delivery Devices market, by country, 2015 - 2026 (USD Million)

    • Table Europe Drug Delivery Devices market, by type, 2015 - 2026 (USD Million)

    • Table Europe Drug Delivery Devices market, by product, 2015 - 2026 (USD Million)

    • Table Europe Drug Delivery Devices market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.K. Drug Delivery Devices market, by type, 2015 - 2026 (USD Million)

    • Table U.K. Drug Delivery Devices market, by product, 2015 - 2026 (USD Million)

    • Table U.K. Drug Delivery Devices market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Germany Drug Delivery Devices market, by type, 2015 - 2026 (USD Million)

    • Table Germany Drug Delivery Devices market, by product, 2015 - 2026 (USD Million)

    • Table Germany Drug Delivery Devices market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table France Drug Delivery Devices market, by type, 2015 - 2026 (USD Million)

    • Table France Drug Delivery Devices market, by product, 2015 - 2026 (USD Million)

    • Table France Drug Delivery Devices market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Italy Drug Delivery Devices market, by type, 2015 - 2026 (USD Million)

    • Table Italy Drug Delivery Devices market, by product, 2015 - 2026 (USD Million)

    • Table Italy Drug Delivery Devices market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Spain Drug Delivery Devices market, by type, 2015 - 2026 (USD Million)

    • Table Spain Drug Delivery Devices market, by product, 2015 - 2026 (USD Million)

    • Table Spain Drug Delivery Devices market, by application, 2015 - 2026 (USD Million)

    • Table Asia Pacific Drug Delivery Devices market, by country, 2015 - 2026 (USD Million)

    • Table Asia Pacific Drug Delivery Devices market, by type, 2015 - 2026 (USD Million)

    • Table Asia Pacific Drug Delivery Devices market, by product, 2015 - 2026 (USD Million)

    • Table Asia Pacific Drug Delivery Devices market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table China Drug Delivery Devices market, by type, 2015 - 2026 (USD Million)

    • Table China Drug Delivery Devices market, by product, 2015 - 2026 (USD Million)

    • Table China Drug Delivery Devices market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Japan Drug Delivery Devices market, by type, 2015 - 2026 (USD Million)

    • Table Japan Drug Delivery Devices market, by product, 2015 - 2026 (USD Million)

    • Table Japan Drug Delivery Devices market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table India Drug Delivery Devices market, by type, 2015 - 2026 (USD Million)

    • Table India Drug Delivery Devices market, by product, 2015 - 2026 (USD Million)

    • Table India Drug Delivery Devices market, by application, 2015 - 2026 (USD Million)

    • Table Latin America Drug Delivery Devices market, by country, 2015 - 2026 (USD Million)

    • Table Latin America Drug Delivery Devices market, by type, 2015 - 2026 (USD Million)

    • Table Latin America Drug Delivery Devices market, by product, 2015 - 2026 (USD Million)

    • Table Latin America Drug Delivery Devices market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Brazil Drug Delivery Devices market, by type, 2015 - 2026 (USD Million)

    • Table Brazil Drug Delivery Devices market, by product, 2015 - 2026 (USD Million)

    • Table Brazil Drug Delivery Devices market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Mexico Drug Delivery Devices market, by type, 2015 - 2026 (USD Million)

    • Table Mexico Drug Delivery Devices market, by product, 2015 - 2026 (USD Million)

    • Table Mexico Drug Delivery Devices market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Argentina Drug Delivery Devices market, by type, 2015 - 2026 (USD Million)

    • Table Argentina Drug Delivery Devices market, by product, 2015 - 2026 (USD Million)

    • Table Argentina Drug Delivery Devices market, by application, 2015 - 2026 (USD Million)

    • Table MEA Drug Delivery Devices market, by country, 2015 - 2026 (USD Million)

    • Table MEA Drug Delivery Devices market, by type, 2015 - 2026 (USD Million)

    • Table MEA Drug Delivery Devices market, by product, 2015 - 2026 (USD Million)

    • Table MEA Drug Delivery Devices market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table South Africa Drug Delivery Devices market, by type, 2015 - 2026 (USD Million)

    • Table South Africa Drug Delivery Devices market, by product, 2015 - 2026 (USD Million)

    • Table South Africa Drug Delivery Devices market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Nigeria Drug Delivery Devices market, by type, 2015 - 2026 (USD Million)

    • Table Nigeria Drug Delivery Devices market, by product, 2015 - 2026 (USD Million)

    • Table Nigeria Drug Delivery Devices market, by application, 2015 - 2026 (USD Million)

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Company market position analysis

    • Table Company Profiles

    • Table Skyepharma Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table COVIDIEN Medtronic Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Roche Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Chiesi Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Catalent Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Novartis AG Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table B.Braun Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Johnson & Johnson Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Zhengkang Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table 3M Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Pfizer Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Phillips-Medisize Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table BBraun Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Boehringer Ingelheim Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Bayer AG Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Baxter International Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Shandong Weigao Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Valeant Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Cipla Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Schott forma vitrum Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Allergan Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table BD Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Alkermes Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Nipro Corporation Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US